MedTrace Logo

Comparing Endoglide to Endoserter for DSAEK Graft Insertion

NCT01791075 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2013-02-15

No results posted yet for this study

Summary

The purpose of this study is to compare the Tan EndoGlide with the new Endoserter injector in terms of damage to the donor corneal endothelium by comparing the endothelial cell loss at 1 month, 3 months, 6 months, and 1 year post DSAEK (Descemet's Stripping Automated Endothelial Keratoplasty)surgery. There is no data comparing this two injectors.

Conditions

  • Fuch's Endothelial Dystrophy
  • Bullous Keratopathy, Unspecified Eye

Interventions

DEVICE

Tan Endoglide

Patients assigned to this intervention will have their endothelial donor graft injected into the anterior chamber using the Tan Endoglide

DEVICE

Endosaver

Patients assigned to this intervention will have their endothelial donor graft injected into the anterior chamber using the Tan Endoglide

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • David S. Rootman, MD · TWH - UHN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01791075 on ClinicalTrials.gov